Publication: Orlistat as a fatty acid synthase inhibitor blocks cell survival mechanism via activating PTEN, which controls PI3K/AKT/MAPK axis in PC3 prostate cancer cells
Program
Authors
Aras, Sahra
Özdemir, Beril Su
Palavan Ünsal, Zeynep Narçın